The immature retinas of preterm neonates are susceptible to insults that disrupt
neurovascular growth, leading to retinopathy of prematurity. Suppression of growth factors …

Retinopathy of prematurity (ROP) is a common blinding disease in children in the developed
world despite current treatment, and is becoming increasingly prevalent in the developing …

Objective To investigate recombinant human insulin-like growth factor 1 complexed with its
binding protein (rhIGF-1/rhIGFBP-3) for the prevention of retinopathy of prematurity (ROP) …

The population of infants at risk for retinopathy of prematurity (ROP) varies by world region;
in countries with well developed neonatal intensive care services, the highest risk infants are …

This article was withdrawn on October 15, 2020, at the request of the journal editors, with
agreement from the authors, owing to a substantial amount of unattributed or improperly …

Retinopathy of prematurity (ROP) is a major complication of preterm birth. It encompasses a
spectrum of pathologies that affect vision, from mild disease that resolves spontaneously to …

BACKGROUND: Early postnatal head growth failure is well recognized in very preterm
infants (VPIs). This coincides with the characteristic nutritional deficits that occur in these …

Retinopathy of prematurity (ROP) is an important cause of childhood blindness globally, and
the incidence is rising. The disease is characterized by initial arrested retinal vascularization …

Background Studies involving adults and children being treated in intensive care units
indicate that insulin therapy and glucose control may influence survival. Hyperglycemia in …

Current update on retinopathy of prematurity: screening and... : Current Opinion in Pediatrics
Current update on retinopathy of prematurity: screening and treatment : Current Opinion in …